Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a revision notice: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision from v3.4.1 to v3.4.2 appears to be a minor site version update with no changes to study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.1 is now displayed on the page, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check61 days agoChange DetectedMinor version update: Revision v3.3.4 was added and Revision v3.3.3 was removed. It does not affect the study details or how users interact with the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page’s Locations section was updated with new investigational sites across multiple countries and with some existing locations removed.SummaryDifference1%

- Check112 days agoChange DetectedPublications section updated: added a sentence clarifying that publications are automatically filled in from PubMed and may or may not be about the study, and removed the previous sentence about automatic creation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.